Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

IL-6-6331 (T/C, rs10499563) is Associated with Decreased Risk of Gastric Cancer in Northern Chinese

  • Yang, Li (Department of Gastroenterology, the First Affiliated Hospital of China Medical University) ;
  • Sun, Ming-Jun (Department of Gastroenterology, the First Affiliated Hospital of China Medical University) ;
  • Liu, Jing-Wei (Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department) ;
  • Xu, Qian (Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department) ;
  • Yuan, Yuan (Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, and Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Provincial Education Department)
  • Published : 2013.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Polymorphisms of genes encoding cytokines could be potential biomarkers to predict risk of gastric cancer (GC). Here, we investigated the association between the IL-6 -6331 (T/C, rs10499563) polymorphism in its promoter region and GC risk. Methods: In this case-control study of 215 GC cases and 518 non-cancer controls, the IL-6 -6331 (T/C, rs10499563) polymorphism was genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: Individuals with the TC or CC genotype were associated with a significantly decreased risk of GC (OR=0.710, 95%CI: 0.504-0.999, P=0.049) compared with TT wild-type carriers. Ther C allele was also associated with significantly decreased risk of GC (OR=0.715, 95%CI: 0.536-0.954, P=0.023) compared with the T allele. In the stratification analysis, TC or CC genotypes were associated with significantly decreased GC risk in subgroups of males, people older than 60, and H. pylori-positive cases. However, no significant interaction was observed for TC or CC genotypes with H. pylori infection. On stratification with the Lauren classification, TC or CC genotypes were associated with significantly decreased risk of diffuse-type GC (OR=0.497, 95%CI: 0.266-0.925, P=0.027), also in subgroups of males, people older than 60, and H. pylori-positive cases. Conclusions: The IL-6 -6331 (T/C, rs10499563) polymorphism is associated with genetic susceptibility of GC and may have the potential to predict GC risk.

Keywords

References

  1. Ashizawa T, Okada R, Suzuki Y, et al (2005). Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer, 8, 124-31. https://doi.org/10.1007/s10120-005-0315-x
  2. Atherton JC (2006). The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Ann Rev Pathol, 1, 63-96. https://doi.org/10.1146/annurev.pathol.1.110304.100125
  3. Bauer J, Ganter U, Geiger T, et al (1988). Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood, 72, 1134-40.
  4. Chen HF, Mai JR, Wan JX, et al (2013). Role of a novel functional variant in the PPP2R1A promoter on the regulation of PP2A-Aalpha and the risk of hepatocellular carcinoma. PLoS One, 8, e59574. https://doi.org/10.1371/journal.pone.0059574
  5. Crabtree JE, Shallcross TM, Heatley RV, et al (1991). Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 32, 1473-7. https://doi.org/10.1136/gut.32.12.1473
  6. Gong YH, Sun LP, Jin SG, et al (2010). Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7, 241 subjects from China. Eur J Clin Microbiol Infect Dis, 29, 907-11. https://doi.org/10.1007/s10096-010-0944-9
  7. He J, Qiu LX, Wang MY, et al (2012). Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet, 131, 1235-44. https://doi.org/10.1007/s00439-012-1152-8
  8. Jarnicki A, Putoczki T, Ernst M (2010). Stat3: linking inflammation to epithelial cancer - more than a “gut” feeling? Cell Div, 5, 14. https://doi.org/10.1186/1747-1028-5-14
  9. Liao WC, Lin JT, Wu CY, et al (2008). Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res, 14, 428-34. https://doi.org/10.1158/1078-0432.CCR-07-1032
  10. Ponder BA (2001). Cancer genetics. Nature, 411, 336-41. https://doi.org/10.1038/35077207
  11. Sipponen P (2002). Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol, 37, 39-44. https://doi.org/10.1007/BF02990098
  12. Sipponen P, Marshall BJ (2000). Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am, 29, 579-92, v-vi. https://doi.org/10.1016/S0889-8553(05)70131-X
  13. Smith AJ, D'Aiuto F, Palmen J, et al (2008). Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism. Clin Chem, 54, 841-50. https://doi.org/10.1373/clinchem.2007.098608
  14. Sugimoto M, Yamaoka Y, Furuta T (2010). Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol, 16, 1188-200. https://doi.org/10.3748/wjg.v16.i10.1188
  15. Waldner MJ, Foersch S, Neurath MF (2012). Interleukin-6--a key regulator of colorectal cancer development. Int J Biol Sci, 8, 1248-53. https://doi.org/10.7150/ijbs.4614
  16. Wang J, He W, Liu J, et al (2012). Association of IL-6 polymorphisms with gastric cancer risk: evidences from a meta-analysis. Cytokine, 59, 176-83. https://doi.org/10.1016/j.cyto.2012.03.032
  17. Yang L, Li Y, Ling X, et al (2011). A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males. PLoS One, 6, e26944. https://doi.org/10.1371/journal.pone.0026944
  18. Yin YW, Sun QQ, Hu AM, et al (2012). Associations between interleukin-6 gene -174 C/G and -572 C/G polymorphisms and the risk of gastric cancer: a meta-analysis. J Surg Oncol, 106, 987-93. https://doi.org/10.1002/jso.23199
  19. Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 9, 798-809. https://doi.org/10.1038/nrc2734
  20. Yu J, Jia Y, Cheung KF, et al (2011). Polymorphisms in interleukin-6-6331 influences the susceptibility of a Chinese population to gastric cancer. Cancer Invest, 29, 564-72. https://doi.org/10.3109/07357907.2011.605411
  21. Yuzhalin A (2011). The role of interleukin DNA polymorphisms in gastric cancer. Hum Immunol, 72, 1128-36. https://doi.org/10.1016/j.humimm.2011.08.003

Cited by

  1. Influence of Propofol, Isoflurane and Enflurance on Levels of Serum Interleukin-8 and Interleukin-10 in Cancer Patients vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6703
  2. Pemetrexed is Mildly Active with Good Tolerability in Treating Patients with Gastric Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7137
  3. IL-1β Polymorphism and Expression Associated with Decreased Risk of Gastric Carcinoma: a Case Control Study in the Ethnic Kashmiri Population, India vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1987
  4. mitotic checkpoint genes contribute to gastric cancer susceptibility vol.58, pp.9, 2017, https://doi.org/10.1002/em.22129